BDBM63924 1-(2-ethoxy-2-oxoethyl)-2-[(2-methoxyphenoxy)methyl]-3-methyl-1H-3,1-benzimidazol-3-ium::2-[2-[(2-methoxyphenoxy)methyl]-3-methyl-1-benzimidazol-3-iumyl]acetic acid ethyl ester::2-[2-[(2-methoxyphenoxy)methyl]-3-methyl-benzimidazol-3-ium-1-yl]acetic acid ethyl ester::MLS001077216::SMR000472999::cid_1106925::ethyl 2-[2-[(2-methoxyphenoxy)methyl]-3-methyl-benzimidazol-3-ium-1-yl]ethanoate::ethyl 2-[2-[(2-methoxyphenoxy)methyl]-3-methylbenzimidazol-3-ium-1-yl]acetate
SMILES N#CCc1cc(NC(=O)c2cc(F)cc(C(F)(F)F)c2)c2c(c1)C(=O)NC2c1cc(F)ccc1Cl
InChI Key InChIKey=CLYXERTWYIMBRP-UHFFFAOYSA-N
Data 1 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 63924
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Relay Therapeutics
US Patent
Relay Therapeutics
US Patent
Affinity DataIC50: 100nMAssay Description:Compounds were added to a 384-well plate. Reaction mixtures contained 10 mM HEPES, pH 7.4, 10 mM MgCl2, 0.01% BSA, 0.0005% Tween 20, 1 mM ATP and 1 M...More data for this Ligand-Target Pair
